Gene editing has become a key tool and is changing drug discovery, writes the Telegraph.

"It has transformed from something that is fantastically difficult to carry out into a day-to-day laboratory technology," Mike Mitchell from Panmure Gordon tells the paper. "It is now vital in both drug discovery and diagnostics and it's oncology and precision medicine that are driving this."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.